214 related articles for article (PubMed ID: 8649407)
1. cis-acting sequences located downstream of the human immunodeficiency virus type 1 promoter affect its chromatin structure and transcriptional activity.
el Kharroubi A; Martin MA
Mol Cell Biol; 1996 Jun; 16(6):2958-66. PubMed ID: 8649407
[TBL] [Abstract][Full Text] [Related]
2. DNase I-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type 1.
Verdin E
J Virol; 1991 Dec; 65(12):6790-9. PubMed ID: 1942252
[TBL] [Abstract][Full Text] [Related]
3. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
Sawaya BE; Khalili K; Amini S
J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
[TBL] [Abstract][Full Text] [Related]
4. Multiple transcriptional regulatory domains in the human immunodeficiency virus type 1 long terminal repeat are involved in basal and E1A/E1B-induced promoter activity.
Kliewer S; Garcia J; Pearson L; Soultanakis E; Dasgupta A; Gaynor R
J Virol; 1989 Nov; 63(11):4616-25. PubMed ID: 2529378
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter.
El Kharroubi A; Piras G; Zensen R; Martin MA
Mol Cell Biol; 1998 May; 18(5):2535-44. PubMed ID: 9566873
[TBL] [Abstract][Full Text] [Related]
6. Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat.
Harrich D; Garcia J; Wu F; Mitsuyasu R; Gonazalez J; Gaynor R
J Virol; 1989 Jun; 63(6):2585-91. PubMed ID: 2657100
[TBL] [Abstract][Full Text] [Related]
7. Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities.
Michael NL; D'Arcy L; Ehrenberg PK; Redfield RR
J Virol; 1994 May; 68(5):3163-74. PubMed ID: 7908701
[TBL] [Abstract][Full Text] [Related]
8. Protein-DNA interactions within DNase I-hypersensitive sites located downstream of the HIV-1 promoter.
el Kharroubi A; Verdin E
J Biol Chem; 1994 Aug; 269(31):19916-24. PubMed ID: 8051074
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes.
Krebs FC; Mehrens D; Pomeroy S; Goodenow MM; Wigdahl B
J Biomed Sci; 1998; 5(1):31-44. PubMed ID: 9570512
[TBL] [Abstract][Full Text] [Related]
10. Conditional regulatory elements of human immunodeficiency virus type 2 long terminal repeat.
Arya SK; Mohr JR
J Gen Virol; 1994 Sep; 75 ( Pt 9)():2253-60. PubMed ID: 8077923
[TBL] [Abstract][Full Text] [Related]
11. Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat.
Zeichner SL; Kim JY; Alwine JC
J Virol; 1991 May; 65(5):2436-44. PubMed ID: 2016766
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element.
Roebuck KA; Rabbi MF; Kagnoff MF
AIDS; 1997 Feb; 11(2):139-46. PubMed ID: 9030359
[TBL] [Abstract][Full Text] [Related]
13. cis-acting regulatory elements in the bovine immunodeficiency virus long terminal repeat.
Fong SE; Pallansch LA; Mikovits JA; Lackman-Smith CS; Ruscetti FW; Gonda MA
Virology; 1995 Jun; 209(2):604-14. PubMed ID: 7778292
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.
Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E
Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615
[TBL] [Abstract][Full Text] [Related]
15. Exon 1 leader sequences downstream of U5 are important for efficient human immunodeficiency virus type 1 gene expression.
Lenz C; Scheid A; Schaal H
J Virol; 1997 Apr; 71(4):2757-64. PubMed ID: 9060629
[TBL] [Abstract][Full Text] [Related]
16. Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration.
Logan AC; Haas DL; Kafri T; Kohn DB
J Virol; 2004 Aug; 78(16):8421-36. PubMed ID: 15280451
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type-1 transcription: role of the 5'-untranslated leader region (review).
Al-Harthi L; Roebuck KA
Int J Mol Med; 1998 May; 1(5):875-81. PubMed ID: 9852310
[TBL] [Abstract][Full Text] [Related]
18. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53.
Subler MA; Martin DW; Deb S
J Virol; 1994 Jan; 68(1):103-10. PubMed ID: 8254719
[TBL] [Abstract][Full Text] [Related]
19. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA
J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
[TBL] [Abstract][Full Text] [Related]
20. Human herpesvirus 6A ts suppresses both transformation by H-ras and transcription by the H-ras and human immunodeficiency virus type 1 promoters.
Araujo JC; Doniger J; Kashanchi F; Hermonat PL; Thompson J; Rosenthal LJ
J Virol; 1995 Aug; 69(8):4933-40. PubMed ID: 7609062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
